Existing evidence to prevent and control antimicrobial resistance is often generated in high-income countries and not always applicable to LMICs. Little attention has been given to identifying what exact solutions are needed in local LMIC-settings. At ICARS, we use intervention and implementation research to test context-specific solutions for LMICs.
The Threat of AMR
When microbes become resistant to antimicrobials such as antibiotics and start to spread, health systems are at risk.
Antimicrobial resistance (or AMR for short) is one of the greatest threats to health, society, and economies worldwide and the World Health Organisation has classified antimicrobial resistance in the top 10 threats to global health.
Vision and Mission
We envisage a world where drug-resistant infections are no longer a threat.
Our mission is to support low- and middle-income countries (LMICs) in their efforts to reduce drug-resistant infections. We are guided by five core principles: country ownership, One Health, partnership, solution-focused and sustainability.
At ICARS we take a holistic One Health approach to creating evidence for policy and action to reduce AMR.
Antimicrobial resistance is a complex issue. The spread of infection between animals, humans and in the environment means that we must move away from isolated interventions in a single sector.
How we work
It is the unique way of working, the “how”, that distinguishes ICARS from others in the AMR landscape.
At ICARS, we simultaneously use top-down and bottom-up approaches, engaging with government ministries while involving local scientists and practitioners throughout the process.